Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2011 | 1 |
2012 | 2 |
2015 | 2 |
2016 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates.
Invest New Drugs. 2012 Apr;30(2):524-8. doi: 10.1007/s10637-010-9585-1. Epub 2010 Nov 12.
Invest New Drugs. 2012.
PMID: 21072558
Free PMC article.
Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction.
Widemann BC.
Widemann BC.
Pediatr Blood Cancer. 2015 Sep;62(9):1512-3. doi: 10.1002/pbc.25577. Epub 2015 May 4.
Pediatr Blood Cancer. 2015.
PMID: 25940351
Free PMC article.
No abstract available.
Item in Clipboard
Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion.
Widemann BC.
Widemann BC.
Pediatr Blood Cancer. 2016 Feb;63(2):366. doi: 10.1002/pbc.25798. Epub 2015 Oct 21.
Pediatr Blood Cancer. 2016.
PMID: 26488622
Free PMC article.
No abstract available.
Item in Clipboard
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group.
Widemann BC, Arceci RJ, Jayaprakash N, Fox E, Zannikos P, Goodspeed W, Goodwin A, Wright JJ, Blaney SM, Adamson PC, Balis FM.
Widemann BC, et al.
Pediatr Blood Cancer. 2011 Feb;56(2):226-33. doi: 10.1002/pbc.22775. Epub 2010 Sep 21.
Pediatr Blood Cancer. 2011.
PMID: 20860038
Free PMC article.
Clinical Trial.
Item in Clipboard
Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias.
Shah NN, Merchant MS, Cole DE, Jayaprakash N, Bernstein D, Delbrook C, Richards K, Widemann BC, Wayne AS.
Shah NN, et al.
Pediatr Blood Cancer. 2016 Jun;63(6):997-1005. doi: 10.1002/pbc.25937. Epub 2016 Feb 17.
Pediatr Blood Cancer. 2016.
PMID: 26891067
Free PMC article.
Clinical Trial.
Item in Clipboard
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
Peer CJ, Sissung TM, Kim A, Jain L, Woo S, Gardner ER, Kirkland CT, Troutman SM, English BC, Richardson ED, Federspiel J, Venzon D, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Widemann B, Figg WD.
Peer CJ, et al.
Clin Cancer Res. 2012 Apr 1;18(7):2099-107. doi: 10.1158/1078-0432.CCR-11-2484. Epub 2012 Feb 3.
Clin Cancer Res. 2012.
PMID: 22307138
Free PMC article.
Item in Clipboard
Cite
Cite